Market Research Global Male Infertility Market Analysis 2018

Male infertility is a widespread disorder, which refers to a male's inability to impregnate his fertile
female partner. It occurs due to deficiencies in semen, poor sperm quality, lower hormonal support, and
abnormal ejaculation.
MIRs analysts forecast the global male infertility market to grow at a CAGR of 5.68% during the period
2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global male infertility market for
2017-2021. To calculate the market size, the report considers the male infertility treatment, which
includes products (drugs) and services.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
MIR's report, Global Male Infertility Market 2017-2021, has been prepared based on an in-depth market
analysis with inputs from industry experts. The report covers the market landscape and its growth
prospects over the coming years. The report also includes a discussion of the key vendors operating in
this market.
Get sample copy of this research report at
https://www.marketinsightsreports.com/reports/03251546/global-male-infertility-market-2017-
2021/inquiry
Key vendors
- ASKA Pharmaceutical
- Halotech DNA
- Merck Serono
- Zydus Cadila Healthcare
Other prominent vendors
- AbbVie
- Apricus Biosciences
- Aytu BioScience
- Bristol-Myers Squibb
- CooperSurgical
- Medical Electronic Systems
- OvaScience
- MedITEX
- Xytex Cryo International
Market driver
- Higher occurrence of diabetes among men
- For a full, detailed list, view our report
Get full access to this report at https://www.marketinsightsreports.com/reports/03251546/global-
male-infertility-market-2017-2021